English Polski
Tom 19, Nr 1-2 (2017)
Prace kazuistyczne
Opublikowany online: 2018-03-05

dostęp otwarty

Wyświetlenia strony 924
Wyświetlenia/pobrania artykułu 1029
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Wewnątrznaczyniowa obliteracja pierwotnych i wtórnych guzów wątroby u chorych zdyskwalifikowanych do leczenia operacyjnego (doniesienie wstępne)

Damian Ziaja1, Mariola Sznapka, Robert Kwiatkowski, Arkadiusz Leszczyna, Jacek Kostyra, Krzysztof Ziaja, Tomasz Gul, Wacław Kuczmik
Chirurgia Polska 2017;19(1-2):28-35.

Streszczenie

U pacjentów zdyskwalifikowanych z leczenia operacyjnego z przyczyn ogólnych, jak i miejscowej nieoperacyjności guza przerzutowego lub pierwotnego wątroby oraz po wyczerpaniu możliwości terapii onkologicznej powinno się podjąć próbę leczenia wewnątrznaczyniowego.

Artykuł dostępny w formacie PDF

Pokaż PDF Pobierz plik PDF

Referencje

  1. Maire F, Lombard-Bohas C, O'Toole D, et al. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: a prospective randomized study. Neuroendocrinology. 2012; 96(4): 294–300.
  2. Xie LL, Sun CJ, Li XD, et al. Arterial embolization of massive hepatocellular carcinoma with lipiodol and gelatin sponge. Indian J Cancer. 2015; 51 Suppl 2: e49–e51.
  3. Fong ZV, Palazzo F, Needleman L, et al. Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver. Am Surg. 2012; 78(11): 1243–1248.
  4. Ljungberg M, Westberg G, Vikhoff-Baaz B, et al. 31P MR spectroscopy to evaluate the efficacy of hepatic artery embolization in the treatment of neuroendocrine liver metastases. Acta Radiol. 2012; 53(10): 1118–1126.
  5. Sharma A, Kaspar M, Siddiqui M, et al. Enucleation after Embolization of Liver Failure-Causing Giant Liver Hemangioma. Am J Case Rep. 2015; 16: 563–567.
  6. Bonomo G, Della Vigna P, Monfardini L. Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session. Cardiovasc Intervent Radiol. 2012; 35(6): 1372–1379.
  7. Sato M, Tateishi R, Yasunaga H, et al. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol. 2012; 47(10): 1125–1133.
  8. Yamakado K, Miyayama S, Hirota S, et al. Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis? Jpn J Radiol. 2012; 30(7): 560–566.
  9. Hiraki T, Koizumi J, Arai Y, et al. Transcatheter arterial embolization of hypervascular tumors with HepaSphere: prospective multicenter open label clinical trial of microspheres in Japan. Jpn J Radiol. 2015; 33(8): 479–486.
  10. Del Prete M, Fiore F, Modica R, et al. Multidisciplinary Group for NeuroEndocrine Tumors of Naples. Hepatic arterial embolization in patients with neuroendocrine tumors. J Exp Clin Cancer Res. 2014; 33: 43.
  11. Topaloğlu S, Oğuz Ş, Kalaycı O, et al. Preoperative arterial embolization of large liver hemangiomas. Diagn Interv Radiol. 2015; 21(3): 222–228.
  12. Kennedy A, Bester L, Salem R, et al. NET-Liver-Metastases Consensus Conference. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference. HPB (Oxford). 2015; 17(1): 29–37.
  13. Ji J, Gao J, Zhao L, et al. Computed tomography-guided radiofrequency ablation following transcatheter arterial embolization in treatment of large hepatic hemangiomas. Medicine (Baltimore). 2016; 95(15): e3402.
  14. Mohanty S, Rajaram R, Bilimoria KY, et al. Assessment of non-surgical versus surgical therapy for localized hepatocellular carcinoma. J Surg Oncol. 2016; 113(2): 175–180.
  15. Sanoff HK, Chang Y, Stavas JM, et al. Effectiveness of initial transarterial chemoembolization for hepatocellular carcinoma among medicare beneficiaries. J Natl Compr Canc Netw. 2015; 13(9): 1102–1110.
  16. Fang ZT, Wang GZ, Zhang W, et al. Transcatheter arterial embolization promotes liver tumor metastasis by increasing the population of circulating tumor cells. OncoTargets and Ther. 2013; 6: 1563.
  17. Park Y, Kim SUp, Kim BK, et al. Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score. Liver Int. 2016; 36(1): 100–107.
  18. Wang S, Yang C, Zhang J, et al. First experience of high-intensity focused ultrasound combined with transcatheter arterial embolization as local control for hepatoblastoma. Hepatology. 2014; 59(1): 170–177.
  19. Lin HM, Lei LM, Zhu J, et al. Risk factor analysis of perioperative mortality after ruptured bleeding in hepatocellular carcinoma. World J Gastroenterol. 2014; 20(40): 14921–14926.